Mast cells and immunological skin diseases

Area of Science:

• Immunology
• Dermatology
• Cell Biology

Background:

• Mast cells are key players in innate and adaptive immunity, particularly in skin immunity.
• Their involvement in immunological skin diseases is supported by extensive literature.
• Mast cells are implicated in the pathogenesis of various skin conditions, including contact dermatitis, atopic dermatitis, immunobullous disease, scleroderma, and chronic graft-vs.-host disease.

Purpose of the Study:

• To review the existing literature on the role of mast cells in the pathogenesis of immunological skin diseases.
• To elucidate the specific contributions of mast cells and their mediators in disease development.
• To explore the potential of mast cell-targeted therapies for inflammatory and autoimmune skin diseases.

Main Methods:

• Literature review of immunological skin diseases.
• Analysis of studies involving mast cell numbers, degranulation, and mediator detection in affected skin.
• Utilisation of animal models, particularly mast cell-deficient mice, to investigate mast cell function.
• Examination of gene polymorphism studies linking mast cell-related genes to disease.

Main Results:

• Mast cells increase in number and degranulate in the skin affected by various immunological diseases.
• Specific mast cell mediators are detected in affected skin, indicating their active role.
• Animal models, especially mast cell-deficient mice, have been instrumental in understanding mast cell contributions.
• Mast cells and their mediators promote fibroblast activation and proliferation, contributing to fibrosis in scleroderma and chronic graft-vs.-host disease.

Conclusions:

• Mast cells are significantly involved in the pathogenesis of multiple immunological skin diseases.
• Further research, including studies on mast cell-deficient mice, is crucial for definitive conclusions.
• Targeting mast cells presents a promising therapeutic strategy for inflammatory and autoimmune skin disorders.